Putting dampers on the cannabis business
Health regulator's classification has set back growth, say industry insiders. But the president says urgent work was being finalised by government to create an enabling environment
12 February 2023 - 07:20
The health regulator has been slammed for hindering growth in the cannabis industry after it classified a cannabis oil compound as a prescription medicine, and some in the sector say slow regulatory reform is also holding back progress.
“We've moved backwards because now they are saying even the non-psychoactive cannabinoids are schedule 6, which makes zero sense and is outside what's happening globally,” said Gabriel Theron, CEO and founder of Cilo Cybin said...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.